Lisa Ness Joins QuadMed as Chief Growth Officer
- None.
- None.
Insights
The appointment of Lisa Ness as Chief Growth Officer at QuadMed, LLC is a strategic move aimed at bolstering the company's position within the competitive healthcare solutions market for employers. Ness's extensive background in worksite health and health coaching, combined with her previous leadership roles, positions her as a valuable asset in driving QuadMed's growth. Her experience with sales at Pfizer and her tenure as Chief Revenue Officer for CareATC highlights her capability in fostering revenue streams and strategic partnerships.
The decision to focus on long-term growth 'thinking in decades, not quarters' suggests a strategic approach that may be more resilient to market volatility, potentially leading to sustainable growth. This could be particularly attractive to investors looking for stability in the healthcare sector. Moreover, Ness's commitment to fostering innovation aligns with QuadMed's mission to remain independent, which could be a key differentiator in a landscape where many competitors are consolidating.
QuadMed's emphasis on innovation and strategic growth under the guidance of Lisa Ness may signal to investors an opportunity for expansion in the employer healthcare solutions market. With Ness's track record, QuadMed could potentially increase its market share by leveraging strategic relationships and capitalizing on the evolving needs of employers. The healthcare industry is known for its rapid transformation and QuadMed's dedication to remaining independent while being supported by Quad, Inc. provides a unique competitive advantage.
Investors should monitor the company's performance indicators following this appointment to gauge the effectiveness of its growth strategies. The utilization of Epic electronic medical record system, a best-in-class resource, could also be indicative of QuadMed's commitment to integrating advanced technologies, which may improve operational efficiencies and patient outcomes, contributing to the company's overall valuation.
From an investment perspective, the appointment of a Chief Growth Officer with Lisa Ness's qualifications could be seen as a proactive measure to enhance QuadMed's value proposition in the healthcare market. Her strategic focus on fostering long-term growth and innovation may lead to the development of new revenue streams and more robust client relationships, which are critical factors in evaluating a company's future revenue potential.
QuadMed's relationship with its parent company, Quad, Inc. and its access to resources like the Epic electronic medical record system, may offer operational synergies that can translate into cost savings and improved margins. These factors could make QuadMed an attractive proposition for investors looking for companies with a clear growth trajectory and the ability to adapt to a rapidly changing healthcare environment.
QuadMed Builds on its Legacy and Current Success as an Independent Innovator of Dynamic, Cost-Effective Health Care Solutions for Employers
Lisa Ness, MBA, RD, CDE. (Photo: Business Wire)
Ness brings deep industry expertise to QuadMed with over 30 years of experience in worksite health, occupational health, health coaching, and pharmacy services. Most recently, Ness served as Chief Revenue Officer for CareATC. Previously, Ness held the positions of Chief Growth Officer for Proactive MD and National Director of Business Development for Premise Health. She has also held sales leadership positions with Pfizer.
"Lisa's alignment with our values and her expertise in cultivating strategic relationships make her a perfect fit for our organization and the way we approach our business. Her style will reinforce our commitment to thinking in decades, not quarters, and will foster the right partnerships with like-minded employers and brokers to not only grow our business, but to grow it deliberately,” said Dr. Kathryn Quadracci Flores, President of QuadMed.
"Joining QuadMed is inspiring, given its status as a family-owned and operated company. Having Quad, a global marketing experience company, as the parent organization provides QuadMed with unrivaled support and investment in best-in-class resources like the Epic electronic medical record system,” Ness said. “In an industry undergoing rapid transformation, QuadMed's unwavering commitment to its over 30-year mission and dedication to remaining independent is one of its greatest strengths and unique differentiators. I look forward to contributing to the company’s rich legacy of fostering innovation and growing through meaningful partnerships.”
About QuadMed
QuadMed (quadmedical.com) is a nationally recognized provider of health and wellness solutions designed specifically for employers. The model features a full continuum of high-quality, patient-centered services proven to decrease costs by increasing accessibility and engagement. The company's 33-year track record of success is rooted in integrating prevention-focused, comprehensive primary care and occupational health with leading-edge technology and analytics. The industry pioneer, QuadMed was founded in 1991 as a subsidiary of Quad.
About Quad
Quad (NYSE: QUAD) is a
Quad employs approximately 15,000 people in 14 countries worldwide and serves more than 2,900 clients across the retail, publishing, consumer packaged goods, financial services, healthcare, insurance and direct-to-consumer industries. Quad is ranked as a leader in multiple industries including largest agency companies (Ad Age, #14); largest commercial printers (Printing Impressions, #2); and largest
For more information about Quad, including its commitment to ongoing innovation, culture and social purpose, visit quad.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240108166001/en/
Liana Wayda
lmwayda@quadmedical.com
414.881.0828
Source: QuadMed, LLC
FAQ
Who is the new Chief Growth Officer of QuadMed, LLC?
What is the ticker symbol for Quad, Inc.?
What is the mission of QuadMed, LLC?
What is Lisa Ness's background?
What are QuadMed's strengths and unique differentiators?
